Sergio Cifuentes Canaval: My abstract was accepted for online presentation at the 2025 ASCO Annual Meeting
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, posted on LinkedIn:
“I’m pleased to share that my abstract was accepted for online presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
Our work, titled ‘Progesterone receptor expression and survival outcomes in metastatic breast cancer’, explores the prognostic role of PR status in the metastatic setting.
Grateful to the entire team and looking forward to contributing to this year’s scientific discussions.”
Sergio Cifuentes Canaval will present his abstract at the 2025 ASCO Annual Meeting. The study investigates how progesterone receptor expression influences survival outcomes in metastatic breast cancer, contributing to ongoing research on hormone receptor profiling in advanced disease.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023